Skip to main content
spacbrain

Immunovant Sciences

Closed (deSPAC)

Health Care · clinical-stage biopharmaceutical company developing antibody

What it is
A private company in health care preparing to list via a SPAC merger. Full profile in progress.
What it’s doing now
Merging with Health Sciences Acquisitions Corp (IMVT) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.
Profile in progress — we only publish what we can verify in filings, and for this company that work isn’t finished. Identity and deal facts above are current; business detail, financials and peers will appear as the filings are parsed.

The deal it’s entering

Immunovant Sciences is merging with Health Sciences Acquisitions Corp (IMVT) currently marked Closed (deSPAC).

Headline equity value—

How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Immunovant Sciences going public?

Immunovant Sciences has an approved merger with the SPAC Health Sciences Acquisitions Corp (IMVT). Deal status: Closed (deSPAC).

Does Immunovant Sciences have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals